INVITATION | SPARK Europe Webinar Series | Team building and how to establish a company | Namir Hassan, CEO at Zelluna Immunotherapy
25th January 2023 | 4-5 pm (CET)
To develop your idea into a growing business you need an excellent and well-functioning team. Learn more about what it takes to build a team and establish and grow a successful business and use the opportunity to discuss with an experienced industry expert during this interactive seminar.
Many don't realize that building a team and bringing in the right expertise is just as critical and as difficult as developing the idea to a final product or solution. If you don’t have the right people on your team or your team can't work together, you have no chance of making a successful business, no matter how great your product is. Which competences do you need when you build your team? What are the pitfalls? What is critical? What are the dos and don'ts?
Namir Hassan has more than 15 years’ experience from biotech and pharma industry with proven success in building innovative, business-focused teams, and leading them to deliver high value. He has expertise in immunotherapy-related topics and broad knowledge in drug discovery. His previous assignments include Vice President at Immuocore, group leader at GSK and visiting lecturer at University of Birmingham. Namir holds a PhD from University of Oxford, where he is currently visiting lecturer.
The webinars are open for all SPARKees, SPARK mentors, and students and staff of SPARK associated organizations.
Register here! Registration to the webinar is required in advance. Please register on 24th January 2023 at the latest.
This webinar is organized by SPARK Norway.
SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Norway, SPARK Poland and SPARK Tel Aviv. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.